Crossmark

Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review

Published Online: 2021-04-22

Published Print: 2021-07

Authors

Huber, D.

Seitz, S.

Kast, K.

Emons, G.

Ortmann, O. https://orcid.org/0000-0001-6238-3949
Funding

Funding for this research was provided by:

Universitätsklinikum Regensburg
License Information

Text and Data Mining valid from 2021-04-22

Version of Record valid from 2021-04-22
More Information

Article History

Received: 16 December 2020

Accepted: 1 April 2021

First Online: 22 April 2021

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current